MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Operating Expenses 2011-2026 | BRKR
Annual Operating Expenses Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 B | 1.08 B | 873 M | 796 M | 678 M | 696 M | 631 M | 583 M | 546 M | 557 M | 646 M | 634 M | 649 M | 584 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 B | 546 M | 739 M |
Quarterly Operating Expenses Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 431 M | 359 M | - | 351 M | 336 M | 288 M | - | 258 M | 254 M | 237 M | - | 204 M | 224 M | 210 M | - | 196 M | 195 M | 190 M | - | 167 M | 148 M | 176 M | - | 166 M | 177 M | 173 M | - | 154 M | 156 M | 161 M | - | 148 M | 149 M | 139 M | - | 139 M | 150 M | 133 M | - | 139 M | 138 M | 145 M | - | 162 M | 165 M | 159 M | - | 162 M | 158 M | 162 M | - | 150 M | 166 M | 156 M | - | 152 M | 145 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 431 M | 133 M | 190 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.19 B | $ 184.69 | 2.23 % | $ 13.8 B |  USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 34.46 | 2.96 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.77 | 3.65 % | $ 1.73 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 292.23 | 1.41 % | $ 8.24 B | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.59 | 0.67 % | $ 36.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.37 | 1.35 % | $ 126 M |  France |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.82 | 1.01 % | $ 94.5 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.34 | -1.71 % | $ 169 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | - | $ 17.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.38 | 3.7 % | $ 294 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 25.21 | 1.47 % | $ 213 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 6.04 | 2.03 % | $ 72.2 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
547 M | $ 94.94 | 2.11 % | $ 12.8 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.98 | -2.46 % | $ 1.2 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.44 | 3.74 % | $ 940 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.79 | 8.49 % | $ 33.1 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.86 | 5.37 % | $ 419 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.88 | 4.11 % | $ 390 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 56.83 | 3.48 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 39.73 | 3.3 % | $ 1.23 B | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 64.99 | 0.63 % | $ 3.55 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 88.63 | 1.03 % | $ 3.08 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.76 | 0.27 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 78.2 | 0.1 % | $ 45.7 B | USA |